Midatech Pharma PLC (MTP): Price and Financial Metrics
MTP Price/Volume Stats
| Current price | $1.14 | 52-week high | $5.25 |
| Prev. close | $0.35 | 52-week low | $0.29 |
| Day low | $1.14 | Volume | 41,075 |
| Day high | $1.40 | Avg. volume | 57,354 |
| 50-day MA | $0.56 | Dividend yield | N/A |
| 200-day MA | $1.96 | Market Cap | 24.71M |
MTP Stock Price Chart Interactive Chart >
Midatech Pharma PLC (MTP) Company Bio
Midatech Pharma PLC focuses on the development and commercialization of multiple, high-value, targeted therapies for major diseases with high unmet medical need in the nanomedicine field.
Latest MTP News From Around the Web
Below are the latest news stories about MIDATECH PHARMA PLC that investors may wish to consider to help them evaluate MTP as an investment opportunity.
Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of EquityBiodexa Pharmaceuticals PLC (AIM:BDRX; Nasdaq:BDRX), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has today issued to various investors 18,636,190 new ordinary shares of £0.02 each in the Company ("New Ordinary Shares"), pursuant to the exercise notices in respect of 1,738,136 A Warrants and 1,989,102 B Warrants received yesterday. |
Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal DiseaseMidatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, is pleased to announce a new research programme coded MTD217 focusing on developing new therapeutic options for metastatic cancers with high unmet needs. |
Midatech Pharma PLC Announces Results of General MeetingMidatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that at the general meeting of the Company held earlier today (the "General Meeting"), all resolutions put to the Company's shareholders ("Shareholders") were duly passed. |
Midatech Pharma PLC Announces Further re: Notice of General MeetingFurther to the announcement made on 8 March 2023 providing notice of a general meeting (the "GM") of the Company to be held on 24 March 2023, and the publication and despatch of a circular to shareholders containing notice of the resolutions to be considered at the GM (the "Notice") and form of proxy (the "Form of Proxy"), the Company announces the following corrections to certain typographical errors identified within the Notice and Form of Proxy: |
Midatech Pharma PLC Announces Posting of Circular and Notice of General MeetingMidatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, announces, further to the Company's announcements of 9 February and 15 February 2023, that a circular (the "Circular") and formal Notice of General Meeting was posted to shareholders yesterday and will be made available on the Company's website at: www.midatechpharma.com/investors/shareholder-information. |
MTP Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -97.03% |
| 5-year | -99.44% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -81.24% |
| 2021 | -43.85% |
| 2020 | -45.74% |
| 2019 | -55.53% |
Continue Researching MTP
Want to do more research on Midatech Pharma Plc's stock and its price? Try the links below:Midatech Pharma Plc (MTP) Stock Price | Nasdaq
Midatech Pharma Plc (MTP) Stock Quote, History and News - Yahoo Finance
Midatech Pharma Plc (MTP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...